Partner Steve Hilfinger was quoted in an Associated Press article, “Tiger Stadium Site Gets New Life as Youth Sports Facility,” about the firm’s work representing the Detroit Police Athletic League in the redevelopment of Tiger Stadium. Foley has been advising Detroit PAL largely on a pro-bono basis since the redevelopment project’s inception five years ago and has led negotiations for land rights and sought new markets tax credits and bridge loans for project financing.
“This would be an exciting project for any firm to work on, but as a firm that has been in downtown Detroit since the founding of our office nearly 20 years ago, it’s especially fulfilling to see this one come together,” said Hilfinger, one of the Foley attorneys who helped on the project.
This article was picked up by The New York Times, The Washington Post (subscription required) and USA Today.
“This would be an exciting project for any firm to work on, but as a firm that has been in downtown Detroit since the founding of our office nearly 20 years ago, it’s especially fulfilling to see this one come together,” said Hilfinger, one of the Foley attorneys who helped on the project.
This article was picked up by The New York Times, The Washington Post (subscription required) and USA Today.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”